Vancouver, Canada, November 4th, 2025, FinanceWire Equity Insider News Commentary – The precision medicine sector reached ...

On Tuesday, Metsera announced that Novo Nordisk's new proposal values the company at up to $86.20 per share, amounting to approximately $10 billion. This offer represents a staggering 159% premium ...

DENVER, Nov. 04, 2025 (GLOBE NEWSWIRE) -- 247marketnews.com, a pioneer in digital media dedicated to the swift distribution of financial market ...

Totipotent Cells: Often regarded as the "holy grail" of stem cell biology, these cells can develop into any type of cell in the body, offering vast possibilities for tissue regeneration.

A new West Coast biotech has emerged into the busy in vivo cell therapy space, this time with the backing of Nobel Prize-winning CRISPR pioneer Jennifer Doudna, Ph.D. Azalea Therapeutics has bloomed ...

2. Mergers and acquisitions are picking up: So far this year, buyouts have boosted several biotech stocks. Some standouts: Regulus Therapeutics went up 120%; 89bio went up 85%; Chimerix gained 69% and ...